Joint Pain Injection Market Size, Share, Growth and Trends, Report 2024-2031

The global joint pain injections market is estimated to reach, growing at a CAGR of 6.8% during the forecast period (2024-2031).

A joint injection, also known as an intra-articular injection, is a medical procedure used to treat various inflammatory joint disorders, including rheumatoid arthritis, psoriatic arthritis, gout, tendinitis, bursitis, Carpal Tunnel Syndrome, and osteoarthritis. During the procedure, a hypodermic needle is inserted into the affected joint to deliver a dose of anti-inflammatory medication, most commonly corticosteroids. In some cases, hyaluronic acid, known for its high viscosity, is used to replace bursa fluids. Additionally, this procedure can be performed to remove excess fluid from the joint, providing relief from pain and inflammation.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/joint-pain-injection-market

Market Dynamics:

Increase in prevalance of arthritis in the market will drive the market growth

The growth of the joint pain injections market is expected to be driven by the increasing prevalence of joint pain in both developed and emerging nations, along with the rapid advancements in injection technologies that enable doctors to quickly diagnose and alleviate the underlying causes of pain. Facet joint injections, which contain a portion of an anesthetic drug to numb the muscles, ligaments, and articular capsules, have seen rising demand as a key non-surgical treatment option for joint pain. This demand is anticipated to significantly contribute to the overall market expansion during the forecast period, with a growing emphasis on effective pain relief.

Arthritis, identified as the leading cause of disability among adults in the United States by the Arthritis Foundation, plays a significant role in this market's growth. Currently, around 54 million people in the U.S., including 300,000 children, suffer from arthritis or another rheumatic disease. Projections indicate that by 2040, over 78 million people in the U.S. will be diagnosed with arthritis. Osteoarthritis, the most prevalent form of arthritis, affects more than 31 million people in the country. The rising incidence of arthritis is expected to drive demand for disease-modifying treatments, further propelling the joint pain injections market during the forecast period.

Segment Covered in the Joint Pain Injection Market:

By Product: Pre-filled injections, Vials.

By Injection Type: Corticosteroid Injections, Hyaluronic Acid Injections, Platelets Rich Plasma Injections, Others.

By Joint Type: Knee and Ankle, Hip, Shoulder and Elbow, Others.

By End User: Hospitals Pharmacies Online Pharmacies, Retail Pharmacies, Others.

Get Customization in the report as per your requierments: https://datamintelligence.com/customize/joint-pain-injection-market

Key players involved in Joint Pain Injection Market:

• Bioventus
• Anika Therapeutics Inc
• Ferring Pharmaceuticals Inc
• Sanofi SA
• Pfizer Inc
• Eli Lilly and Company
• Flexion Therapeutics Inc
• Teva Pharmaceuticals
• Zimmer Biomet
• Dr.Reddy Laboratories

Related Reports:

Breast Pump Market: https://www.datamintelligence.com/research-report/breast-pump-market

Orthobiologics Market: https://www.datamintelligence.com/research-report/orthobiologics-market

Personal Mobility Device Market: https://www.datamintelligence.com/research-report/personal-mobility-device-market

Product Portfolio:

Durolane

Durolane is a viscosupplement that mimics the natural fluid found in your body's joints. This fluid acts as both a lubricant and a shock absorber, helping to cushion and protect the joints during movement. Durolane is primarily used to treat knee pain associated with osteoarthritis and is often prescribed when other arthritis treatments have not provided adequate relief. By replenishing the joint fluid, Durolane helps to reduce pain and improve joint function.

Regional Analysis:

The global Joint Pain Injection Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Joint Pain Injection Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.